Andrew Thrukauf

Title: The Innovations of Andrew Thrukauf

Introduction

Andrew Thrukauf is an accomplished inventor based in Ridgefield, CT (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of receptor modulators. His work focuses on creating compounds that can effectively modulate receptor activity, which has important implications for treating various medical conditions.

Latest Patents

Thrukauf holds a patent for "Substituted biaryl amides C5a receptor modulators." This patent describes substituted biaryl amides of Formula I, which serve as ligands that can modulate C5a receptor activity both in vivo and in vitro. These compounds are particularly useful in treating conditions associated with pathological C5a receptor activation in humans, domesticated companion animals, and livestock. The patent also includes pharmaceutical compositions and methods for using these ligands in receptor localization studies.

Career Highlights

Andrew Thrukauf is currently associated with Neurogen Corporation, where he continues to innovate in the field of receptor modulation. His work has the potential to lead to new therapeutic approaches for various diseases, enhancing the quality of life for many patients.

Collaborations

Thrukauf collaborates with talented colleagues, including Yang Gao and He Zhao, who contribute to the research and development efforts at Neurogen Corporation.

Conclusion

Andrew Thrukauf's innovative work in receptor modulation exemplifies the impact of scientific research on healthcare. His contributions are paving the way for new treatments that could benefit both humans and animals.